Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Calculate exactly how many units of PT-141 to draw on your syringe. Pre-filled with standard defaults.
Draw on your syringe
35
units
(0.350 mL)
35.0% of syringe capacity
Concentration
5,000
mcg/mL
Dose volume
0.350
mL
Doses per vial
5
doses
Cost per dose
---
enter price
Total mcg in vial = 10 mg x 1000 = 10,000 mcg
Concentration = 10,000 mcg / 2 mL = 5,000 mcg/mL
Dose volume = 1750 mcg / 5,000 mcg/mL = 0.3500 mL
Units to draw = 0.3500 mL x 100 units/mL = 35 units
Doses per vial = 10,000 mcg / 1750 mcg = 5.71 doses
Want the full Disclosed Trust Index?
Create a free account to unlock vendor trust scores, the COA scanner, the Forgery Map, and lot lookup across the corpus.
Create a free accountPT-141 (Bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist derived from Melanotan II. FDA-approved as Vyleesi (NDA 210557, 2019) at 1.75mg SubQ for premenopausal women with hypoactive sexual desire disorder — not approved in men. Use as-needed only; per the Vyleesi label, administer at least 45 minutes before anticipated sexual activity. Max once per 24 hours, max 8 doses per month; discontinue if no benefit after 8 weeks. Screen for cardiovascular disease and uncontrolled hypertension before use; avoid alcohol around dosing. Do NOT combine with Melanotan II or other melanocortin agonists.
Common vial size
10
mg
Typical BAC water
2
mL
Dose range
1000–2000
mcg
Default dose
1750
mcg
Store unreconstituted vials refrigerated (2-8°C). Once reconstituted, store refrigerated and use within 14 days. Sensitive to degradation — minimize temperature fluctuations.
Disclosed Labs